Technical Analysis for DICE - DICE Therapeutics, Inc.

Grade Last Price % Change Price Change
B 27.77 -5.86% -1.73
DICE closed up 10.49 percent on Monday, October 18, 2021, on 78 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical DICE trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -5.86%
Multiple of Ten Bearish Other -5.86%
Wide Bands Range Expansion -5.86%
Up 3 Days in a Row Strength -5.86%
Up 4 Days in a Row Strength -5.86%
Narrow Range Bar Range Contraction 4.01%
NR7 Range Contraction 4.01%
NR7-2 Range Contraction 4.01%
Wide Bands Range Expansion 4.01%
Up 3 Days in a Row Strength 4.01%
Older End-of-Day Signals for DICE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day 41 minutes ago
Down 5% about 2 hours ago
60 Minute Opening Range Breakdown about 3 hours ago
Down 3% about 3 hours ago
20 DMA Resistance about 4 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

DICE Therapeutics, Inc. Description

DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It designs and develops therapies in immunology for patients with chronic diseases. The company's lead therapeutic candidate, S011806, is an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17), which is a validated drug target implicated in various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin and aVß1/aVß6 integrin for the treatment of inflammatory bowel disease and idiopathic pulmonary fibrosis. The company was founded in 2013 and is headquartered in South San Francisco, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Health Sciences Pharmacy Inflammation Inflammatory Bowel Disease Idiopathic Pulmonary Fibrosis Chronic Diseases Treatment Of Inflammatory Bowel Disease

Is DICE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.5
52 Week Low 23.69
Average Volume 167,434
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 29.95
10-Day Moving Average 26.96
Average True Range 3.70
ADX 0.0
+DI 12.12
-DI 14.17
Chandelier Exit (Long, 3 ATRs) 29.42
Chandelier Exit (Short, 3 ATRs) 34.78
Upper Bollinger Bands 36.50
Lower Bollinger Band 23.41
Percent B (%b) 0.47
BandWidth 43.70
MACD Line -2.70
MACD Signal Line -2.25
MACD Histogram -0.4522
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.68
Resistance 3 (R3) 35.26 32.78 34.65
Resistance 2 (R2) 32.78 31.21 32.99 34.31
Resistance 1 (R1) 31.14 30.23 31.96 31.56 33.96
Pivot Point 28.66 28.66 29.07 28.87 28.66
Support 1 (S1) 27.02 27.09 27.84 27.44 25.04
Support 2 (S2) 24.54 26.11 24.75 24.69
Support 3 (S3) 22.90 24.54 24.35
Support 4 (S4) 23.32